Ann Arbor, MINCT06784336Now EnrollingIRB Ready

Allogeneic Stem Cell Transplant Clinical Trial in Ann Arbor, MI

Access cutting-edge allogeneic stem cell transplant treatment through this phase 2 clinical trial at a research site in Ann Arbor. Study-provided care at no cost to qualified participants.

Sponsored by University of Michigan Rogel Cancer Center

Quick Self-Assessment

See if you qualify for this Ann Arbor location

Preparing your pre-screening questions…

Expert Care in Ann Arbor

Access allogeneic stem cell transplant specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related allogeneic stem cell transplant treatment provided free

Apply for This Ann Arbor Location

Check if you qualify for this allogeneic stem cell transplant clinical trial in Ann Arbor, MI

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Ann Arbor

    Convenient for MI residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Ann Arbor site if eligible
  4. 4Begin participation

About This Allogeneic Stem Cell Transplant Study in Ann Arbor

The study will evaluate the safety and early efficacy of administering the combination of a commercially available potato-based resistant starch along with iron chelation therapy to subjects undergoing alloHCT.

Sponsor: University of Michigan Rogel Cancer Center

Who Can Participate

Inclusion Criteria

Patients with hematologic disorders undergoing allo-HCT from fully HLA-matched unrelated or related donors after full-intensity conditioning regimen
Age ≥18 years
Karnofsky performance status \>70%, see Appendix A
Patients must be able to swallow capsules/tablets
Ability to understand and the willingness to sign a written informed consent
Availability of a full-HLA matched related or unrelated donor who is medically eligible to donate cells according to the National Marrow Donor Program criteria

Exclusion Criteria

Patients with active inflammatory bowel disease requiring treatment per treating investigator
Patients with a history of gastric bypass surgery
Patients with active Clostridium difficile infection at the time of study enrollment. Active infection is defined as a stool sample positive for Clostridium difficile toxin via enzyme immunoassay (EIA) and either symptoms (frequent loose stools) OR imaging findings consistent with toxic megacolon
Patients with active iron deficiency anemia requiring treatment
Patients with iron overload receiving active treatment with deferasirox
Known hypersensitivity to deferasirox or any component of Jadenu or Exjade
Patients actively enrolled on treatment or in follow up phase on any other GVHD prevention trial
Any physical or psychological condition that, in the opinion of the investigator, would pose an unacceptable risk to the patient or raise concern that the patient would not comply with protocol procedures

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Ann Arbor?

Yes, this clinical trial (NCT06784336) has an active research site in Ann Arbor, MI that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Allogeneic Stem Cell Transplant Treatment Options in Ann Arbor, MI

If you're searching for allogeneic stem cell transplant treatment options in Ann Arbor, MI, this clinical trial (NCT06784336) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Ann Arbor research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced allogeneic stem cell transplant specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all allogeneic stem cell transplant clinical trials near you to find additional studies recruiting in your area.

More Leukemia Trials in Ann Arbor, MI

See all leukemia clinical trials recruiting in Ann Arbor — not just this study.

Browse Leukemia Trials in Ann Arbor →

Browse More Trials by Condition

Leukemia TrialsRheumatoid Arthritis TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Ann Arbor?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Ann Arbor, MI